2026 Global: Companion Animal Blood Glucose Monitoring Market -Competitive Review (2032) report
Description
The 2026 Global: Companion Animal Blood Glucose Monitoring Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for companion animal blood glucose monitoring market by geography and historical trend. The scope of the report extends to sizing of the companion animal blood glucose monitoring market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Zoetis, IDEXX Laboratories, Merck Animal Health (including its MSD Animal Health portfolio), Elanco, and Heska are widely recognized among the ten major companies in the companion animal blood glucose monitoring market for their integrated diagnostic and animal-health offerings, combining species-specific glucometers, test strips, and clinic-focused solutions to serve veterinarians and pet owners worldwide. Zoetis markets the AlphaTRAK series, a veterinary-calibrated glucose monitoring system with companion apps and consumables that has strong adoption in clinics and at-home monitoring. IDEXX leverages its large veterinary diagnostics footprint and in-clinic analyzers to support glucose monitoring workflows and data integration for practice-based diabetes management. Merck Animal Health and Elanco both provide product portfolios and distribution networks that position them as leading suppliers of diabetes care tools and related services within the broader pet-health ecosystem. Heska focuses on point-of-care diagnostic instruments and consumables tailored to companion animals, strengthening practice-level glucose testing capabilities and electronic record linkage for management of diabetic patients.
Regional and specialty device manufacturers round out the top-ten roster, including Trividia Health (and its veterinary-focused brands), ACON Laboratories, i-SENS, UltiMed (and related CGM/glucometer innovators), and AccuBioTech/Taidoc and similar diagnostic suppliers that supply veterinary-calibrated meters, strips, and increasingly continuous glucose monitoring (CGM) solutions for pets. Trividia and allied blood-glucose device companies supply validated meters and strip technologies used in veterinary settings and by pet owners, often emphasizing compatibility and cost-effectiveness. ACON and i-SENS are notable for their diagnostic reagent and electrochemical-sensor expertise, offering veterinary-appropriate test strips and handheld devices that meet demand across clinics and retail channels. UltiMed and newer entrants like AccuBioTech and Taidoc have expanded offerings to include small-animal CGMs and connectivity features that support continuous monitoring and telehealth integration, responding to the market trend toward real-time data and remote management.
Market dynamics across these ten companies reflect consolidation of diagnostics and animal-health services, growth in CGM adoption, and competing strategies focused on species-specific calibration, data connectivity, and distribution through veterinary channels and online retail. Industry reports list these firms among leading players and emphasize innovations such as Zoetis’s AlphaTRAK 3 launch, distribution partnerships for pet CGMs (for example ALR/partner arrangements), and increasing investment in point-of-care and continuous monitoring technologies that accelerate uptake among veterinarians and tech-savvy pet owners. Analysts highlight that the market growth is driven by rising pet ownership, increasing incidence of diabetes in dogs and cats, and demand for easier at-home monitoring—factors that favor companies able to provide accurate, user-friendly meters, reliable consumables, and integrated software ecosystems for long-term diabetes management in companion animals.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for companion animal blood glucose monitoring market by geography and historical trend. The scope of the report extends to sizing of the companion animal blood glucose monitoring market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Zoetis, IDEXX Laboratories, Merck Animal Health (including its MSD Animal Health portfolio), Elanco, and Heska are widely recognized among the ten major companies in the companion animal blood glucose monitoring market for their integrated diagnostic and animal-health offerings, combining species-specific glucometers, test strips, and clinic-focused solutions to serve veterinarians and pet owners worldwide. Zoetis markets the AlphaTRAK series, a veterinary-calibrated glucose monitoring system with companion apps and consumables that has strong adoption in clinics and at-home monitoring. IDEXX leverages its large veterinary diagnostics footprint and in-clinic analyzers to support glucose monitoring workflows and data integration for practice-based diabetes management. Merck Animal Health and Elanco both provide product portfolios and distribution networks that position them as leading suppliers of diabetes care tools and related services within the broader pet-health ecosystem. Heska focuses on point-of-care diagnostic instruments and consumables tailored to companion animals, strengthening practice-level glucose testing capabilities and electronic record linkage for management of diabetic patients.
Regional and specialty device manufacturers round out the top-ten roster, including Trividia Health (and its veterinary-focused brands), ACON Laboratories, i-SENS, UltiMed (and related CGM/glucometer innovators), and AccuBioTech/Taidoc and similar diagnostic suppliers that supply veterinary-calibrated meters, strips, and increasingly continuous glucose monitoring (CGM) solutions for pets. Trividia and allied blood-glucose device companies supply validated meters and strip technologies used in veterinary settings and by pet owners, often emphasizing compatibility and cost-effectiveness. ACON and i-SENS are notable for their diagnostic reagent and electrochemical-sensor expertise, offering veterinary-appropriate test strips and handheld devices that meet demand across clinics and retail channels. UltiMed and newer entrants like AccuBioTech and Taidoc have expanded offerings to include small-animal CGMs and connectivity features that support continuous monitoring and telehealth integration, responding to the market trend toward real-time data and remote management.
Market dynamics across these ten companies reflect consolidation of diagnostics and animal-health services, growth in CGM adoption, and competing strategies focused on species-specific calibration, data connectivity, and distribution through veterinary channels and online retail. Industry reports list these firms among leading players and emphasize innovations such as Zoetis’s AlphaTRAK 3 launch, distribution partnerships for pet CGMs (for example ALR/partner arrangements), and increasing investment in point-of-care and continuous monitoring technologies that accelerate uptake among veterinarians and tech-savvy pet owners. Analysts highlight that the market growth is driven by rising pet ownership, increasing incidence of diabetes in dogs and cats, and demand for easier at-home monitoring—factors that favor companies able to provide accurate, user-friendly meters, reliable consumables, and integrated software ecosystems for long-term diabetes management in companion animals.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.